• 1
    McConnell JD, Barry MJ, Bruskewitz RC et al. Benign prostatic hyperplasia: Diagnosis and Treatment. Clinical Practice Guidelines, Number 8. AHCPR Publication No. 94–0582. Agency for Health Care Policy and Research, Public Health Service. Rockville: Department of Health and Human Services (US); 1994.
  • 2
    Kojima M, Naya Y, Inoue W et al. The American Urological Association symptom index for benign prostatic hyperplasia as a function of age. Volume and ultrasonic appearance of the prostate. J. Urol. 1997; 157: 21606.
  • 3
    Kojima M, Ochiai A, Naya Y, Ukimura O, Watanabe M, Watanabe H. Correlation of presumed circle area ratio with intravesical obstruction in men with lower urinary tract symptoms. Urology 1997; 50: 54855.
  • 4
    Kurita Y, Masuda H, Terada H, Suzuki K, Fujita K. Transition zone index as a risk factor for acute urinary retention in benign prostatic hyperplasia. Urology 1998; 51: 595600.
  • 5
    McNeal J. Pathology of benign prostatic hyperplasia. Insight into etiology. Urol. Clin. North Am. 1990; 17: 47786.
  • 6
    Rifkin MD, Sudakoff GS, Alexander AA. Prostate: techniques, results, and potential applications of color Doppler US scanning. Radiology 1993; 186: 50913.
  • 7
    Neumaier CE, Martinoli C, Derchi LE, Silvestri E, Rosenberg I. Normal prostate gland: Examination with color Doppler US. Radiology 1995; 196: 4537.
  • 8
    Rifkin MD. Ultrasound of the Prostate – Imaging in the Diagnosis and Therapy of Prostatic Disease, 2nd edn. Philadelphia, Lippincott-Raven, 1997.
  • 9
    Kojima M, Watanabe H, Watanabe M, Okihara K, Naya Y, Ukimura O. Preliminary results of power Doppler imaging in benign prostatic hyperplasia. Ultrasound Med. Biol. 1997; 23: 13059.
  • 10
    Hendrikx A, Klomp M, Keyzer J, Arends B, Zonneveld G. The role of velocity imaging (CVI) in prostate ultrasound. Eur. J. Ultrasound 1996; 3: 1523.
  • 11
    Rubin JM, Bude RO, Carson PL, Bree RL, Adler RS. Power Doppler: A potentially useful alternative to mean-frequency based color Doppler sonography. Radiology 1994; 190: 8536.
  • 12
    Nelson TR, Pretorius DH. The Doppler signal: Where does it come from and what does it mean? Am. J. Radiol. 1988; 151: 43947.
  • 13
    Barry MJ, Fowler FJ Jr, O'Leary MP et al. The American Urological Association symptom index for benign prostatic hyperplasia. J. Urol. 1992; 148: 154977.
  • 14
    Ohe H. Benign prostatic hypertrophy. In: Watanabe H, Holms JH, Holm HH, Goldberg BB (eds). Diagnostic Ultrasound in Urology and Nephrology. Igaku-Shoin, Tokyo, 1981; 1239.
  • 15
    Kaplan SA, Te AE, Pressler LB, Olsson CA. Transition zone index as a method of assessing benign prostatic hyperplasia: Correlation with symptoms, urine flow and detrusor pressure. J. Urol. 1995; 154: 17649.
  • 16
    Saloner R, Seppanen K, Rauramaa R, Salonen JT. Pre-valence of carotid atherosclerosis and serum cholesterol levels in Eastern Finland. Arteriosclerosis 1988; 8: 78892.
  • 17
    Handa N, Matsumoto M, Maeda H et al. Ultrasonic evaluation of early carotid atherosclerosis. Stroke 1990; 2: 156772.